IRCT20230225057533N1招募中2 期
Evaluation the effect of prolonging the duration of administration of Colistin infusion on the Colistin-induced nephrotoxicity
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •At least 18 years old
- •Infection with Multidrug resistance organism
- •Sputum culture be positive with Acinetobacter baumannii , Klebsiella pneumoniae
排除标准
- •Discontinue treatment with colistin
- •Receiving other nephrotoxic drugs at the same time
- •Oliguria (urine output less than 500 cc in 24 hours)
- •Hypotension due to a reason other than sepsis (embolism, MI, hypovolemic shock),
- •receiving NSAIDs
- •Receive albumin
- •receiving contrast agents
- •Estimated glomerular filtration rate (eGFR) less than 5 mL/min/1.73 m2
研究者
相似试验
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-CZBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-BGBayer AG102
已完成
3 期
An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090ROPretinopathy of prematurityNL-OMON49661Bayer2
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-SKBayer AG102
进行中（未招募）
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090Retinopathy of prematurityEUCTR2018-003180-54-BEBayer AG102